Reneo Pharmaceuticals, Inc.

RPHM · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents$70,331$83,374$96,661$110,761
Short-Term Investments$0$0$0$0
Receivables$0$0$0$0
Inventory$0$0$0$0
Other Curr. Assets$1,195$1,178$1,511$2,242
Total Curr. Assets$71,526$84,552$98,172$113,003
Property Plant & Equip (Net)$1,205$1,402$1,601$1,795
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$104$116$109$109
Total NC Assets$1,309$1,518$1,710$1,904
Other Assets$0$0$0$0
Total Assets$72,835$86,070$99,882$114,907
Liabilities
Payables$1,290$2,381$2,344$2,968
Short-Term Debt$567$556$546$536
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$4,390$4,660$5,895$7,026
Total Curr. Liab.$6,247$7,597$8,785$10,530
LT Debt$120$267$409$549
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$40$40$40$0
Total NC Liab.$160$307$449$549
Other Liabilities$0$0$0$0
Cap. Leases$687$823$955$1,085
Total Liabilities$6,407$7,904$9,234$11,079
Equity
Pref Stock$0$0$0$114,907
Common Stock$1$1$1$1
Retained Earnings-$200,738-$186,039-$170,649-$154,724
AOCI$0$0$0$0
Other Equity$267,165$264,204$261,296$258,551
Total Equity$66,428$78,166$90,648$103,828
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$72,835$86,070$99,882$114,907
Net Debt-$69,644-$82,551-$95,706-$109,676